Our aim is to study lipid metabolism in the development of obesity-induced insulin resistance and type 2 diabetes. This inlcudes in vitro and in vivo mechanistic studies to find new approaches to combat obesity through the following research lines:
- Enhancing adipose tissue thermogenesis.
- Adipose tissue in adults and children with obesity (childhood obesity and new biomarkers in obesity).
Funding in Process
- 2023 - presentUnravelling the human brown adipose tissue secretome and its implication in obesity CIBEROBN Intramural (Coordinator: Jonatan Ruiz)
- 2022 - presentCentro de Investigación Biomédica en Red Fisiopatología de la Obesidad y Nutrición (CIBEROBN) CB06/03/0001. Instituto de Salud Carlos III (PI: Laura Herrero)
- 2021 - presentModulation of the adipose tissue and AgRP neurons’ lipid metabolism to counteract obesity and diabetes MICIN/AEI (PI: Laura Herrero/Dolors Serra)
Past Funding
- 2021 - 2023Adipose tissue-derived stem cells gene therapy to combat obesity and associated metabolic diseases Merck Health Foundation (PI: Laura Herrero)
- 2021 - 2023Investigación traslacional en Obesidad: Generación de una Cohorte Multicéntrica Prospectiva CIBER para el Estudio de la Obesidad (CoMCEO) – Estudios Genéticos, Epigenéticos y Hormonales, y relación con Cohortes Singulares Preexistentes CIBEROBN (Coordinator: Manuel Tena-Sempere; Co-IP: Laura Herrero)
- 2020 - 2022Unraveling the pathophysiology of adipose tissue of obese children through next-generation RNA sequencing (KIDSADIPOSEQ) CIBEROBN intramural project (OBN20PI03/2020) (Coordinator: Laura Herrero)
- 2020 - 2023Immunometabolic Profiling in Obesity-Associated Diabetes Qatar National Research Fund (Coordinator: Nicholas Van Panhuys; Co-PI: Laura Herrero)
- 2019 - 2021Drug delivery targeting Brain CPT1: a novel nanomedicine-based approach to fight obesity and cancer (CONCORD) Japanese Medical Research Agency (AMED) & National Research Agency (AEI) (PI: Rosalía Rodríguez-Rodríguez)